OS Therapies OSTX Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $7.35M-16.4% | $8.8M+134% | $3.76M+50.2% | $2.5M+90.9% | $1.31M+50.4% | ||
| $2.82M-11.7% | $3.19M+2.1% | $3.12M+33.6% | $2.34M-36.6% | $3.69M+76.1% | ||
| -$10.17M+15.2% | -$11.99M-74.3% | -$6.88M-42.2% | -$4.84M+3.2% | -$5M-68.5% | ||
| $75.34K— | —— | —— | —— | —— | ||
| -$228.89K+84.5% | -$1.47M-2,266,163% | $65-100.0% | $302.11K-73.1% | $1.12M+4,625% | ||
| 50%0.0% | 50%— | —— | —— | 50%0.0% | ||
| -$10.4M+22.8% | -$13.46M-95.7% | -$6.88M-51.6% | -$4.54M-17.0% | -$3.88M-29.6% | ||
| -$0.27+34.1% | -$0.41-95.2% | -$0.21-10.5% | -$0.19-5.6% | -$0.18+71.9% | ||
| -$10.04M+15.3% | -$11.86M-75.6% | -$6.75M-42.9% | -$4.73M+5.5% | -$5M-68.6% | ||
| -$10.17M+15.2% | -$11.99M-74.3% | -$6.88M-42.2% | -$4.84M+3.2% | -$5M-68.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is OS Therapies profitable?
- OS Therapies is not currently profitable: it reported a net loss of $35.3M over the trailing twelve months.
- What is OS Therapies's earnings per share?
- OS Therapies's diluted EPS over the trailing twelve months is $-1.08.
- Where does OS Therapies's income statement data come from?
- Every line is extracted from OS Therapies's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.